Accelerate Diagnostics, Inc Quarterly Nonoperating Income (Expense) in USD from Q2 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Accelerate Diagnostics, Inc quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2019 to Q3 2024.
  • Accelerate Diagnostics, Inc Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$6.02M, a 138% decline year-over-year.
  • Accelerate Diagnostics, Inc Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was -$14.8M, a 157% decline year-over-year.
  • Accelerate Diagnostics, Inc annual Nonoperating Income (Expense) for 2023 was -$6.74M, a 2968% decline from 2022.
  • Accelerate Diagnostics, Inc annual Nonoperating Income (Expense) for 2022 was $235K.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$14.8M -$6.02M -$21.7M -138% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $6.93M -$2.98M +$17M +85.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$10.1M -$4.07M -$3.34M -456% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 -$6.74M -$1.7M -$978K -135% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-29
Q3 2023 -$5.76M $15.7M +$16.6M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$22.4M -$20M -$19.5M -3644% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$2.93M -$733K -$3.16M -130% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 $235K -$726K +$2.62M +78.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q3 2022 -$2.39M -$935K -$6.48M -117% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $4.1M -$534K +$3.55M +86.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $545K $2.43M +$6.64M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$6.1M -$3.35M Oct 1, 2021 Dec 31, 2021 10-K 2024-03-29
Q3 2021 $5.55M +$9.14M Jul 1, 2021 Sep 30, 2021 10-Q/A 2023-03-03
Q2 2021 -$4.08M -$579K -16.5% Apr 1, 2021 Jun 30, 2021 10-Q/A 2023-03-03
Q1 2021 -$4.21M -$633K -17.7% Jan 1, 2021 Mar 31, 2021 10-Q/A 2023-03-03
Q3 2020 -$3.59M -$572K -18.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$3.51M -$794K -29.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 -$3.58M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q3 2019 -$3.02M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 -$2.71M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.